Series A funding round for GenSight Biologics raising $42M in April 2013
Series A funding round for GenSight Biologics raising $42M in April 2013
| Investor | Firm Type | Partner |
|---|
NovartisLEAD | Private | — |
Index VenturesLEAD | Venture Capital | — |
AbingworthLEAD | Venture Capital | — |
Versant VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$78M
Top Valuation
-
GenSight Biologics raised $42M in a Series A round.
The round was announced on 04/01/13.
The round was led by Abingworth, Versant Ventures, Index Ventures, Florent Gros.